Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases. Its peptide-based drugs are made of a naturally occurring antagonist that modulates fat metabolism and dysregulation of glycemia in diabetic patients.